PubMed

Oxford PharmaGenesis insights into patient-reported outcomes (PROs), health literacy and patient-centricity were the subject of the September edition of the International Society for Medical Publication Professionals (ISMPP) online education series, ISMPP University (ISMPP U).

Today, the Right Honourable Edward Vaizey, local MP for Wantage, visited award-winning HealthScience communications consultancy Oxford PharmaGenesis to discuss the implications of Brexit for trade, education, research and health funding in Oxfordshire.

We are delighted to announce that Sorcha Bangham has joined Oxford PharmaGenesis as our Learning and Development Manager.

A simple scoring system can predict the chances of children with a respiratory tract infection being admitted to hospital, thereby helping to target antibiotics more appropriately. This important finding is highlighted in a commentary written by Chris Winchester, Managing Director of Oxford PharmaGenesis, and colleagues, which is published today in Lancet Respiratory Medicine.

I strongly believe that entering a workplace can be an extremely daunting prospect. Will the other employees be friendly? Am I going to like the work? What if I do something wrong? These are questions that I have asked myself before each work experience. However, in the case of this work experience, these turned out […]

With the success of Team GB at this year’s Olympics in Rio, Oxford PharmaGenesis refused to miss out on all the fun. We held our own Office Games in Oxford to raise money for the charity Worldwide Cancer Research (www.worldwidecancerresearch.org), which funds promising cancer research in world-renowned institutions across the globe. The company sponsored each […]

Oxford PharmaGenesis was proud to present the results of its research into the benefits of medical writing support for randomized controlled trial (RCT) reporting at the fifth Evidence Live conference, held at the University of Oxford, 22–24 June 2016.

Oxford PharmaGenesis is celebrating a third award for their original research demonstrating that professional medical writing support improves the quality of clinical trial reporting. “We’re delighted that our independent research has again been recognized as an important milestone for our industry”, says co-author and Commercial Director, Dr Richard White.